Contact Alcon Trial Center for Trial Locations
Fort Worth, Texas, 76134, United States
NCT Number: NCT01211535
The purpose of this study was to assess the comfort of OPTI-FREE RepleniSH in soft contact lens wearers.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Fort Worth, Texas, 76134, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
FDA-approved, multipurpose solution used as indicated for cleaning, rinsing, conditioning, disinfecting, and storing study contact lenses on a daily wear basis for 14 days
Other names: OPTI-FREE® RepleniSH®
FDA-approved, multipurpose solution used as indicated for cleaning, disinfecting, daily protein removing, and storing study contact lenses on a daily wear basis for 14 days
Other names: ReNu Biotrue™
Silicone hydrogel contact lenses per subject's habitual brand and prescription worn on a daily wear basis for 14 days, with either OPTI-FREE RepleniSH or ReNu Biotrue used for contact lens care
Time frame: Baseline (Day 0), Day 14
Ocular comfort was rated by the participant on a continuous visual analog scale from 0-100, where 0=extremely uncomfortable, 50=neither comfortable nor uncomfortable, and 100=extremely comfortable. The participant marked a horizontal line across the scale at the point that best described, "how your eyes feel right now." A positive number indicates increased ocular comfort; a negative number indicates decreased ocular comfort.
Alcon Research
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01912768
Astigmatism, Eye Diseases
View Trial DetailsNCT01912781
Astigmatism, Eye Diseases
View Trial DetailsNCT01699750
Astigmatism, Eye Diseases
Fort Worth, Texas, United States
View Trial DetailsNCT01858701
Astigmatism, Eye Diseases
View Trial Details